Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

The new assay can help develop products for hair re-growth.

Targeting the AhR pathway may help treat alopecia areata.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

The combination therapy was effective and well-tolerated, especially in young patients.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Cholesteatoma shows abnormal and increased EGF receptor expression, indicating its rapid growth.

c-Kit is important for heart regeneration and cancer development.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

A specific gene change is linked to severe hair loss.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

XEDAR triggers a specific signaling pathway in cells.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Enhancing Tregs can protect against alopecia areata.

PCFCL may have unrecognized subtypes and needs more research.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.